Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement
Künye
Yilmaz, R., Adas, G., Cukurova, Z., Isiksacan, N., Oztel, O. N., & Karaoz, E. (2020). Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement. Bratislavske lekarske listy, 121(12), 847-852.Özet
The aim of this study is to evaluate the therapeutic effect of mesenchymal stem cells (MSCs) in a severe case of brain and multiple organ involvement in a patient with COVID-19. Here, a 51-year-old male patient with multi-organ involvement due to COVID-19 infection and developing cardiac arrest is presented. MSCs were transplanted to the patient four times systematically and once intrathecally. As a result, the application of MSCs has been found to have a healing effect on organs in this patient with severe COVID-19 infection. In addition, transplantation of MSCs both systematically and intrathecally is considered to be effective in the treatment of the central nervous system (Tab. 2, Fig. 2, Ref. 24). Text in PDF www.elis.sk
